Robert O. Dillman, MD, FACP
Caladrius Biosciences · Hoag Memorial Hospital Presbyterian · Cancer Biotherapy Research Group
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Robert O. Dillman, MD, FACP as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:10 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00814593 · Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by SurgeryLisata Therapeutics, Inc. · withdrawn · Brain and Central Nervous System Tumors · principal investigator
- Ph2NCT00436930 · Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic MelanomaHoag Memorial Hospital Presbyterian · completed · Melanoma (Skin) · study chair
- Ph2NCT00331526 · Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma MultiformeHoag Memorial Hospital Presbyterian · completed · Brain and Central Nervous System Tumors · study chair
- Ph2NCT00004040 · Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After ChemotherapyHoag Memorial Hospital Presbyterian · withdrawn · Leukemia, Multiple Myeloma and Plasma Cell Neoplasm · study chair
- Ph2NCT00004039 · Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV LymphomaHoag Memorial Hospital Presbyterian · withdrawn · Lymphoma · study chair
- Ph2NCT00003605 · Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's LymphomaHoag Memorial Hospital Presbyterian · withdrawn · Lymphoma · study chair
- Ph2NCT00003663 · Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's LymphomaHoag Memorial Hospital Presbyterian · withdrawn · Lymphoma · study chair
- Ph2NCT00002506 · Isotretinoin Plus Interferon in Treating Patients With Recurrent CancerHoag Memorial Hospital Presbyterian · completed · Cervical Cancer, Esophageal Cancer, Head and Neck Cancer · study chair
- Ph2NCT00002504 · Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic CancerHoag Memorial Hospital Presbyterian · completed · Chronic Myeloproliferative Disorders, Leukemia, Lymphoma · study chair
- Ph2NCT00003091 · High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or MelanomaHoag Memorial Hospital Presbyterian · completed · Kidney Cancer, Melanoma (Skin) · study chair
- Ph2NCT00002733 · Biological Therapy in Treating Patients With Metastatic CancerHoag Memorial Hospital Presbyterian · completed · Kidney Cancer, Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific · study chair
- Ph2NCT00002505 · Tumor Cell Vaccine in Treating Patients With Advanced CancerHoag Memorial Hospital Presbyterian · completed · Unspecified Adult Solid Tumor, Protocol Specific · study chair
- Ph1/Ph2NCT00012064 · Vaccine Therapy in Treating Patients With Stage IV or Recurrent MelanomaLisata Therapeutics, Inc. · completed · Melanoma (Skin) · study chair
- Ph1NCT00014131 · Vaccine Therapy in Treating Patients With Kidney CancerLisata Therapeutics, Inc. · terminated · Kidney Cancer · study chair
- Ph2NCT00049413 · Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic LymphomaHoag Memorial Hospital Presbyterian · completed · Leukemia, Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.